ISRCTN95257778已完成不适用
KALL R2 - Acute Lymphoblastic Leukaemia trial
Medical Research Council (MRC) (UK)0 个研究点目标入组 200 人开始时间: 2000年4月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •They are children under 15 years at original diagnosis and treated on UKALL trials or pilot studies with first relapse less than 4 years from the start of treatment of ALL at any site and no suitable related bone marrow treatment (BMT) donor is available
排除标准
- •1. They are multiply relapsed patients
- •2. They have a prior history of toxicity or organ damage such that completion of the protocol is felt unlikely at the outset
- •3. They have had an isolated CNS or testicular relapse more than 6 months off treatment.
研究者
相似试验
已完成
不适用
Acute lymphoblastic leukaemia (ALL) trial XII (joint trial with Eastern Co-operative Oncology Group - E2993)eukaemiaCancerLeukaemiaISRCTN77346223Medical Research Council (MRC) (UK)550
已完成
不适用
KALL XI (92) - Acute lymphoblastic leukaemia trialeukaemiaAcute lymphoblastic leukaemiaCancerISRCTN16757172Medical Research Council (MRC) (UK)2,090
已完成
不适用
Acute Myeloid Leukaemia (AML) Trial 12 (modified) for patients aged under 60eukaemia (acute)LeukaemiaCancerISRCTN55678797Medical Research Council (MRC) (UK)500
已完成
不适用
Medical Research Council Acute Lymphoblastic Leukaemia Trial in Children UKALL R1eukaemia (acute)CancerLeukaemiaISRCTN13327255Medical Research Council (MRC) (UK)256
已完成
不适用
Acute myeloid leukaemia (AML) trial 12 (protocol for children)eukaemiaLeukaemiaCancerISRCTN64649191Medical Research Council (MRC) (UK)2,000